22h agoInvesting.com MarketsNEUTRAL 50General
Why is STAAR Surgical stock climbing today?
Why is STAAR Surgical stock climbing today?
Archived explainer. For the current picture see today's STAA page.
Why Is STAAR SURGICAL CO (STAA) Stock Up Today?
By the Top Tier Newswire AI Desk · September 25, 2026 at 9:30 AM ET · reviewed against 5 wire stories
STAAR SURGICAL CO (STAA) is up +6.03% in the latest session. Our newswire has captured 5 stories on STAA across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 67/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why STAA stock is up today
STAAR Surgical Co (STAA) rose 6.03% to $20.23 in early trading on news of a $50 million share repurchase authorization. The move followed a prior close of $19.08 and a 4.3% gap up at the open. The company plans to use free cash flow and cash on hand for the buyback, which covers up to 5% of its shares outstanding. The announcement came amid a backdrop of recent earnings that beat estimates and ongoing analyst coverage, though the stock has declined significantly from its 52-week high of $35.87.
What Happened
The board of STAAR Surgical Co approved a $50 million share repurchase program over the next 12 months. The company reported $181.5 million in cash, cash equivalents, and investments available for sale as of July 3, 2026. The buyback authorization is intended to return capital to shareholders and reflect confidence in the company’s financial position. The stock opened at $19.89 and reached an intraday high of $20.30 before settling near the open. The move follows a second-quarter earnings report that beat both revenue and earnings estimates.
What The Data Shows
The stock has fallen 17.3% over the last eight sessions, from $23.07 to $19.08. On September 24, it printed two fresh 52-week lows and four fresh 52-week highs. The 52-week range is $15.59 to $35.87. STAA has a market cap of $992.9 million and a P/E ratio of 248.0. Revenue has grown 51.3% in the trailing twelve months, but net margin remains at 1.1%. The stock has a beta of 1.22, indicating higher volatility than the market. Volume so far in the session is 0.0 million shares, which is 0.0 times the 3-month average.
What To Watch
The company has no earnings scheduled in the near term. Investors may watch for changes in coverage breadth or further corporate actions.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
STAA by the numbers
Last: $20.23Session: +6.03%7 sessions: -10.17%Coverage: 5 stories / 4 sourcesAI sentiment: 67/100 (bullish)Mkt cap: $993MP/E: 248.052w: $15.59 to $35.87
The headlines behind the move
22h agoInvesting.com MarketsBULLISH 71General
STAAR Surgical stock ticks higher on $50M buyback authorization
STAAR Surgical stock ticks higher on $50M buyback authorization
22h agoThe FlyBULLISH 71General
Staar Surgical approves $50M share repurchase authorization
22h agoSeeking AlphaBULLISH 71General
STAAR Surgical authorizes $50M share buyback
STAAR Surgical (STAA) approves a $50M share buyback over 12 months—up to ~5% of shares. See funding, cash position, and impact.
23h agoStockTitanBULLISH 71General
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
STAAR intends to use free cash flow and cash on hand; as of July 3, 2026, it had $181.5 million in cash, cash equivalents and investments available for sale.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on STAA: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier STAA move explainers: 2026-09-25